Dynamický nákupní systém na služby spojené s testováním klinických kandidátních léčiv pro Univerzitu Palackého v Olomouci 2024-2027
Czechia · Olomouc · how to bid here →
Your path to submission
- Deadline: 31 December 2027 at 09:00 — 454 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: SLK, CES.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- 2% of the bids received came from other countries (310 procedures with a bid mix) — all bidders, not just the winners. Sector: 30%.n = 310
- 19% of this buyer's awards went to companies that had already won here before (1,581 awards since 2015, spread over 261 companies). 81% went to new names.n = 1,581 awards since 2015
- The median procedure drew just one bid (1,200 procedures with a bid count); 50% ended with a single bidder. Sector: median 2 bids.n = 1,200
- 78% of the bids received came from small and medium-sized enterprises (310 procedures with a bid mix). Sector: 55%.n = 310
- The award came in at a median 95% of the estimated value (227 awards with both estimate and value) — pricing at the estimate is usually too high here.n = 227
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 02/10/2026.
Foreign bidders
In Czechia, 2,457 contracts went to foreign companies over the last 3 years (of 127,586 recorded awards) — mostly from Germany, France, Poland.
Typical field: median 2 (from 89 awards).
What the buyer is looking for
The subject of performance is services consisting in the testing of clinical candidate drugs under the GLP regime and in the production of clinical batches of candidate drugs under the GMP regime. In order to authorise a clinical trial of medicinal products (to submit an application to the regulator), the sponsor needs to document specialised studies and manufacturing documentation of the production of clinical batches of medicinal products (including synthesis, validation studies, formulation, release by a qualified person, etc.) under the GMP regime and biological studies (acute and chronic toxicity, pharmacokinetics, etc.) under the GLP regime. The subject matter of specific public contracts awarded in a dynamic purchasing system will always be specified in the invitation to tender within the meaning of Section 141 of the Act.
What you must prove — eligibility criteria
Dodavatel prokazuje splnění podmínek základní způsobilosti stanovených v § 74 odst. 1 písm. a) - e) Zákona formou dle § 75 odst. 1 písm. a) - f) Zákona. Dodavatel prokazuje splnění profesní způsobilosti dle § 77 Zákona ve vztahu k České republice předložením: … ▸▾
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| GeneTiCA s.r.o. | 18 | 2022–2026 |
| VWR International s.r.o. | 14 | 2022–2026 |
| Aricoma Systems a.s. | 14 | 2024–2026 |
| PREMO s.r.o. | 13 | 2022–2026 |
| BioTech a.s. | 12 | 2015–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.